Childhood cancer mutagenesis caused by transposase-derived PGBD5
Projects
Optimized cross-linking mass spectrometry for in situ interaction proteomics
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas
Urine proteomics for profiling of human disease using high accuracy mass spectrometry.
